Sponsor or institution
Clinical trials and research at Exavir Therapeutics INC.
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $3.0 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Ultra-long-acting, self-administered HIV treatment for HIV and HIV/HBV co-infection
A new, long-lasting HIV treatment regimen that you could self-administer and potentially reduce frequent clinic visits, with a focus on people living with HIV and HIV/HBV co-infection.
-
XVIR-110: ultra-long-lasting injectable HIV prevention
Developing a single injectable medicine that could protect adults and adolescents at risk of HIV for many months with fewer clinic visits.
-
A new long-lasting treatment to prevent HIV infection
This study is testing a new long-lasting injection to help prevent HIV in people at risk, making it easier for them to stay protected without needing to visit the clinic as often.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.